OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tumor neoantigens: Novel strategies for application of cancer immunotherapy
Hanyang Guan, Yue Wu, Lu Li, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2023) Vol. 31, Iss. 4, pp. 437-448
Open Access | Times Cited: 15
Hanyang Guan, Yue Wu, Lu Li, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2023) Vol. 31, Iss. 4, pp. 437-448
Open Access | Times Cited: 15
Showing 15 citing articles:
Development of antibody‐drug conjugates in cancer: Overview and prospects
Dan‐Yun Ruan, Hao‐Xiang Wu, Qi Meng, et al.
Cancer Communications (2023) Vol. 44, Iss. 1, pp. 3-22
Open Access | Times Cited: 23
Dan‐Yun Ruan, Hao‐Xiang Wu, Qi Meng, et al.
Cancer Communications (2023) Vol. 44, Iss. 1, pp. 3-22
Open Access | Times Cited: 23
Treatment strategies and drug resistance mechanisms in adenocarcinoma of different organs
Xing Peng, Shuo Wang, Yu Cao, et al.
Drug Resistance Updates (2023) Vol. 71, pp. 101002-101002
Open Access | Times Cited: 22
Xing Peng, Shuo Wang, Yu Cao, et al.
Drug Resistance Updates (2023) Vol. 71, pp. 101002-101002
Open Access | Times Cited: 22
Pan-cancer analysis of RNA 5-methylcytosine reader (ALYREF)
Xing Ye, Zhouting Tuo, Kai Chen, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 3, pp. 503-515
Open Access | Times Cited: 5
Xing Ye, Zhouting Tuo, Kai Chen, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 3, pp. 503-515
Open Access | Times Cited: 5
Epigenetic modulation of immune cells: Mechanisms and implications
Stefano Fiordoro, Camillo Rosano, Eugenia Pechkova, et al.
Advances in Biological Regulation (2024) Vol. 94, pp. 101043-101043
Closed Access | Times Cited: 4
Stefano Fiordoro, Camillo Rosano, Eugenia Pechkova, et al.
Advances in Biological Regulation (2024) Vol. 94, pp. 101043-101043
Closed Access | Times Cited: 4
The immunopeptidome of colon cancer cells treated with topoisomerase inhibiting drug reveals differential as well as common endogenous protein sampling and display of MHC I-associated peptides
Deepa Bedi, Md. Imtaiyaz Hassan, Alehegne Yirsaw, et al.
Molecular & Cellular Oncology (2025) Vol. 12, Iss. 1
Open Access
Deepa Bedi, Md. Imtaiyaz Hassan, Alehegne Yirsaw, et al.
Molecular & Cellular Oncology (2025) Vol. 12, Iss. 1
Open Access
Immune Modulation and Immunotherapy in Solid Tumors: Mechanisms of Resistance and Potential Therapeutic Strategies
Suman Giri, Gopal Lamichhane, Jitendra Pandey, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 2923-2923
Open Access
Suman Giri, Gopal Lamichhane, Jitendra Pandey, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 2923-2923
Open Access
Trial watch: anticancer vaccination with dendritic cells
Francisca Borges, Raquel S. Laureano, Isaure Vanmeerbeek, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Francisca Borges, Raquel S. Laureano, Isaure Vanmeerbeek, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Extracellular vesicles-based vaccines: Emerging immunotherapies against cancer
Yuhua Meng, Zhimeng Yao, Xiurong Ke, et al.
Journal of Controlled Release (2024) Vol. 378, pp. 438-459
Open Access | Times Cited: 2
Yuhua Meng, Zhimeng Yao, Xiurong Ke, et al.
Journal of Controlled Release (2024) Vol. 378, pp. 438-459
Open Access | Times Cited: 2
Nucleic acid‐based vaccine for ovarian cancer cells; bench to bedside
Sulieman Ibraheem Shelash Al‐Hawary, Saade Abdalkareem Jasim, Ahmed Hjazi, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 2
Closed Access | Times Cited: 1
Sulieman Ibraheem Shelash Al‐Hawary, Saade Abdalkareem Jasim, Ahmed Hjazi, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 2
Closed Access | Times Cited: 1
Design, synthesis and antitumor activity of 3,4,5-Trisubstituted Isoxazoles
Kanghui Duan, Fuxing Tan, Hongming Xie, et al.
European Journal of Medicinal Chemistry Reports (2024) Vol. 12, pp. 100203-100203
Open Access | Times Cited: 1
Kanghui Duan, Fuxing Tan, Hongming Xie, et al.
European Journal of Medicinal Chemistry Reports (2024) Vol. 12, pp. 100203-100203
Open Access | Times Cited: 1
The journey of antibody-drug conjugates for revolutionizing cancer therapy: A review
Fatima Akram, Amna M. Ali, Muhammad Tayyab Akhtar, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 117, pp. 118010-118010
Closed Access | Times Cited: 1
Fatima Akram, Amna M. Ali, Muhammad Tayyab Akhtar, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 117, pp. 118010-118010
Closed Access | Times Cited: 1
Immunotherapy of Solid Tumors Based on Neoantigen Vaccines
Elahe Aleebrahim‐Dehkordi, Amir Ghaffari Jolfayi, Nima Rezaei
Springer eBooks (2024), pp. 1-19
Closed Access
Elahe Aleebrahim‐Dehkordi, Amir Ghaffari Jolfayi, Nima Rezaei
Springer eBooks (2024), pp. 1-19
Closed Access
Multifaceted perspectives of detecting and targeting solid tumors
Abhishek Bhattacharya, Anjan Kr. Dasgupta
International review of cell and molecular biology (2024), pp. 1-66
Closed Access
Abhishek Bhattacharya, Anjan Kr. Dasgupta
International review of cell and molecular biology (2024), pp. 1-66
Closed Access
Prospects and challenges of neoantigen applications in oncology
Ranran Shi, Ling Ran, Yuan Tian, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113329-113329
Closed Access
Ranran Shi, Ling Ran, Yuan Tian, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113329-113329
Closed Access
Therapeutic In Situ Cancer Vaccine Using Pulsed Stereotactic Body Radiotherapy—A Translational Model
Kumara Swamy
Vaccines (2023) Vol. 12, Iss. 1, pp. 7-7
Open Access | Times Cited: 1
Kumara Swamy
Vaccines (2023) Vol. 12, Iss. 1, pp. 7-7
Open Access | Times Cited: 1
Harnessing Immunity to Treat Advanced Thyroid Cancer
Hiroki Komatsuda, Michihisa Kono, Risa Wakisaka, et al.
Vaccines (2023) Vol. 12, Iss. 1, pp. 45-45
Open Access | Times Cited: 1
Hiroki Komatsuda, Michihisa Kono, Risa Wakisaka, et al.
Vaccines (2023) Vol. 12, Iss. 1, pp. 45-45
Open Access | Times Cited: 1
